M
Markus Kreuz
H指数:49
被引数:1.8万
浏览量:0
个人简介
暂无内容
教育背景
暂无内容
工作经历
暂无内容
荣誉奖项
暂无内容
Unsupervised risk factor identification across cancer types and data modalities via explainable artificial intelligence
基于可解释人工智能的跨癌症类型和数据模态的无监督风险因素识别
npj Digital Medicine
IF15.1
Endothelial dysfunction and proinflammatory state determine severe hematotoxicity and inferior outcome of CAR-T therapy
内皮功能障碍和促炎状态决定CAR-T疗法的严重血液毒性及较差的疗效
HEMASPHERE
IF14.6
A longitudinal single-cell atlas to predict outcome and toxicity after BCMA-directed CAR T cell therapy in multiple myeloma
一项纵向单细胞图谱研究,用于预测多发性骨髓瘤中BCMA靶向CAR T细胞疗法后的结局和毒性。
Cancer Cell
IF44.5
Design specifications for biomedical virtual twins in engineered adoptive cellular immunotherapies
工程化嵌合细胞免疫疗法中生物医学虚拟双胞胎的设计规范
npj Digital Medicine
IF15.1
Predicting progression events in multiple myeloma from routine blood work
预测多发性骨髓瘤进展事件来自常规血液检查
NPJ DIGITAL MEDICINE
IF15.1
Age- and gender-specific molecular characteristics of diffuse large B-cell lymphoma: Results from clinical trials of the DSHNHL/GLA
弥漫大B细胞淋巴瘤的年龄和性别特异性分子特征:来自DSHNHL/GLA临床 trial 的结果
HEMASPHERE
IF14.6
The use of steroids associated with PD1/PDL-1 blockage in patients with brain metastasis: A systematic review and meta-analysis
与PD1/PDL-1阻断相关的糖皮质激素在脑转移患者中的使用:一项系统评价和Meta分析
ANNALS OF ONCOLOGY
IF65.4
Impact of statin therapy on mortality and recurrence in female breast cancer: A meta-analysis
他汀类药物疗法对女性乳腺癌患者死亡率和复发率的影响:一项Meta分析
ANNALS OF ONCOLOGY
IF65.4
Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas
形成生发中心衍生的b细胞淋巴瘤的编码和非编码基因组的突变机制
LEUKEMIA
IF13.4

